Search results
Eli Lilly (LLY) Gets FDA Nod for Alzheimer's Drug Donanemab
Zacks via Yahoo Finance Canada· 3 weeks agoEli Lilly's (LLY) Alzheimer's disease drug, Kisunla (donanemab), wins FDA approval. Kisunla will be...
FDA Approves Second Alzheimer’s Drug after Trial Shows it Can Slow Disease by 35%
The Daily Beast via Yahoo Canada News· 3 weeks agoThe Federal Drug Administration gave the go-ahead to a second Alzheimer’s treatment Tuesday after a...
CHMP to Delay Nod on Biogen (BIIB), Eisai's Alzheimer's Drug
Zacks via Yahoo Finance Canada· 4 months agoPer Biogen (BIIB)/Eisai, the delay in CHMP recommendation for lecanemab is entirely related to...
Lilly's (LLY) Donanemab Betters Biogen's Alzheimer's Drug
Zacks via Yahoo Finance Canada· 2 years agoData from a phase III early symptomatic Alzheimer's disease study shows that Eli Lilly's (LLY)...
Biogen (BIIB), Eisai Alzheimer Drug Gets FDA Panel Endorsement
Zacks via Yahoo Finance Canada· 1 year agoAn FDA advisory committee supports granting full approval to Biogen (BIIB)/Eisai's Alzheimer's...
Lilly drug slows Alzheimer's progression by 35% in trial
Reuters via Yahoo Finance Canada· 1 year agoAn experimental Alzheimer's drug developed by Eli Lilly and Co slowed cognitive decline by 35% in a...
Biogen (BIIB) to Stop Selling Alzheimer's Disease Drug Aduhelm
Zacks via Yahoo Finance Canada· 6 months agoBiogen (BIIB) aims to build a leading Alzheimer's disease franchise with the new drug Leqembi. The...
Eli Lilly says Alzheimer’s drug approval delayed as FDA seeks input from advisers
CNN via Yahoo News· 5 months agoDrugmaker Eli Lilly says that approval of its experimental Alzheimer’s medication donanemab will be...
Biogen (BIIB) Stock Down Despite FDA Nod to Alzheimer's Drug
Zacks via Yahoo Finance Canada· 1 year agoBiogen’s BIIB stock was down on Friday despite FDA’s long-awaited full approval to its and partner...
'Game changer': Alzheimer's drug lecanemab slows progression of disease in global study
Yahoo News· 2 years agoOver 6 million Americans are living with Alzheimer’s. But experts say there is hope on the horizon,...